Source published Nov 3, 2026, 08:21 PM UTC · Operation recorded Nov 4, 2026, 12:01 AM UTC

Form 144 shows officer Patrick Finn proposing to sell 2,565 common shares acquired via restricted stock vesting on 11/02/2026, with the filing noting the sale covers a tax obligation from a vested equity award distribution. Prior sales in the past three months are also disclosed. This is a routine insider equity-award disposition, not a material catalyst or impairment of Twist Bioscience's expected fundamentals, and no fresh prior system signal exists to preserve, so the evidence is non-actionable.